Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.17 Insider Own21.76% Shs Outstand93.09M Perf Week-8.78%
Market Cap476.07M Forward P/E- EPS next Y-0.67 Insider Trans0.91% Shs Float88.48M Perf Month-5.50%
Income-109.19M PEG- EPS next Q-0.18 Inst Own52.41% Short Float9.13% Perf Quarter-14.08%
Sales5.35M P/S88.98 EPS this Y34.72% Inst Trans3.16% Short Ratio6.11 Perf Half Y200.71%
Book/sh2.12 P/B1.98 EPS next Y14.04% ROA-38.26% Short Interest8.08M Perf Year159.88%
Cash/sh1.57 P/C2.68 EPS next 5Y23.30% ROE-44.20% 52W Range1.11 - 6.72 Perf YTD0.24%
Dividend Est.- P/FCF- EPS past 5Y-46.78% ROI-43.82% 52W High-37.35% Beta2.32
Dividend TTM- Quick Ratio7.19 Sales past 5Y37.94% Gross Margin-160.16% 52W Low278.90% ATR (14)0.37
Dividend Ex-Date- Current Ratio7.19 EPS Y/Y TTM-7.72% Oper. Margin-1733.55% RSI (14)36.00 Volatility7.78% 7.19%
Employees156 Debt/Eq0.06 Sales Y/Y TTM-13.72% Profit Margin-2042.00% Recom1.33 Target Price8.60
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q13.40% Payout- Rel Volume0.66 Prev Close4.35
Sales Surprise-57.22% EPS Surprise-3.92% Sales Q/Q-29.24% EarningsMay 14 BMO Avg Volume1.32M Price4.21
SMA20-13.18% SMA50-17.32% SMA20029.55% Trades Volume873,895 Change-3.22%
Date Action Analyst Rating Change Price Target Change
Mar-14-24Initiated Scotiabank Sector Outperform $13
Dec-05-23Initiated KeyBanc Capital Markets Overweight $3
May-04-23Initiated H.C. Wainwright Buy $4
Aug-12-22Downgrade JP Morgan Overweight → Underweight
Jul-18-22Initiated Truist Buy $8
Mar-02-22Resumed Cowen Market Perform
Feb-01-22Initiated Berenberg Buy $28
Nov-10-21Downgrade BofA Securities Neutral → Underperform $10
Oct-15-21Resumed Cowen Market Perform
Aug-16-21Initiated Stifel Hold $28
May-20-24 09:32PM
May-16-24 07:15AM
May-15-24 03:01AM
May-14-24 11:53AM
03:26PM Loading…
May-12-24 03:26PM
May-07-24 09:13AM
Apr-16-24 08:00AM
Apr-10-24 11:07AM
Mar-28-24 04:05PM
Mar-23-24 05:31AM
Mar-21-24 02:52PM
Mar-12-24 05:34PM
Mar-06-24 06:34AM
04:01PM Loading…
Mar-01-24 04:01PM
Feb-27-24 10:20PM
Feb-21-24 07:30AM
Feb-20-24 08:00AM
Feb-05-24 09:40AM
Jan-10-24 07:30AM
Jan-08-24 07:00AM
Jan-03-24 08:00AM
Dec-28-23 08:00AM
Dec-20-23 07:30AM
Dec-05-23 08:11AM
Dec-04-23 07:30AM
01:27AM Loading…
Dec-03-23 01:27AM
Nov-15-23 08:00AM
Nov-14-23 06:15PM
Oct-26-23 08:00AM
Sep-21-23 08:00AM
Sep-06-23 08:00AM
Aug-28-23 04:05PM
Aug-14-23 03:51PM
Aug-10-23 08:00AM
Aug-01-23 08:00AM
Jul-26-23 08:00AM
Jun-15-23 08:00AM
Jun-07-23 09:32AM
Jun-06-23 08:00AM
May-15-23 05:45PM
May-11-23 08:00AM
May-03-23 10:00AM
Apr-06-23 08:00AM
Apr-04-23 08:00AM
Apr-01-23 08:25AM
Mar-30-23 04:05PM
Mar-23-23 08:00AM
Mar-07-23 08:00AM
Feb-28-23 08:00AM
Feb-21-23 08:00AM
Feb-09-23 08:00AM
Feb-08-23 08:00AM
Jan-10-23 10:36AM
Jan-08-23 03:13PM
Dec-29-22 07:17AM
Dec-28-22 08:00AM
Nov-23-22 08:00AM
Nov-17-22 08:00AM
Nov-09-22 10:47AM
Nov-02-22 04:05PM
Oct-26-22 08:00AM
Oct-04-22 07:00AM
Sep-28-22 06:44AM
Sep-01-22 08:00AM
Aug-24-22 07:00AM
Aug-15-22 04:00PM
Aug-11-22 09:15AM
Aug-10-22 10:50AM
Aug-02-22 11:17AM
Aug-01-22 08:00AM
Jul-26-22 02:23PM
Jul-22-22 07:25AM
Jul-21-22 07:00AM
Jul-14-22 07:05AM
Jul-07-22 07:05AM
Jun-16-22 05:48PM
Jun-14-22 06:06PM
Jun-13-22 11:37AM
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Redmile Group, LLCDirectorMar 01 '24Buy4.50222,222999,9998,253,316Mar 05 09:30 PM